[Diabetes mellitus, coronary artery disease and heart disease (Update 2023)]
- PMID: 37101042
- PMCID: PMC10133371
- DOI: 10.1007/s00508-023-02183-7
[Diabetes mellitus, coronary artery disease and heart disease (Update 2023)]
Abstract
Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with preexisting diabetes mellitus. In patients with previously diagnosed arterosclerotic cardiovascular disease an agent proven to reduce major adverse cardiovascular events or cardiovascular mortality is recommended.
Die Zusammenhänge zwischen Diabetes mellitus, koronarer Herzkrankheit und Herzinsuffizienz sind wechselseitig. Bei Erstmanifestation einer koronaren Herzkrankheit sollte aktiv auf Diabetes mellitus gescreent werden, während bei an Diabetes mellitus erkrankten Patient:innen die kardiovaskuläre Risikostratifizierung immer in Zusammenschau sämtlicher Risikofaktoren, Biomarker und dem klinischen Befinden des Patient:innen durchgeführt werden sollte. Eine bereits bekannte kardiovaskuläre Erkrankung wie auch das Vorliegen zahlreicher Risikofaktoren stellen wesentliche Kriterien für die Auswahl der individuellen Therapiestrategien dar.
Keywords: Coronary artery disease; Diabetes mellitus; Heart failure; Heart failure in diabetes; Screening.
© 2023. The Author(s).
Similar articles
-
[Diabetes mellitus, coronary artery disease und heart disease (Update 2019)].Wien Klin Wochenschr. 2019 May;131(Suppl 1):169-173. doi: 10.1007/s00508-019-1488-3. Wien Klin Wochenschr. 2019. PMID: 30980152 Review. German.
-
[Diabetes mellitus, coronary artery disease and heart disease].Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S212-5. doi: 10.1007/s00508-016-0988-7. Wien Klin Wochenschr. 2016. PMID: 27052249 Review. German.
-
High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.Cardiovasc Diabetol. 2019 Dec 17;18(1):171. doi: 10.1186/s12933-019-0974-2. Cardiovasc Diabetol. 2019. PMID: 31847896 Free PMC article.
-
Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Circulation. 2013 Aug 20;128(8):785-94. doi: 10.1161/CIRCULATIONAHA.112.000678. Epub 2013 Jul 15. Circulation. 2013. PMID: 23857320 Free PMC article. Clinical Trial.
-
Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial.Lancet Public Health. 2024 Feb;9(2):e88-e99. doi: 10.1016/S2468-2667(23)00269-4. Epub 2023 Dec 19. Lancet Public Health. 2024. PMID: 38134944 Clinical Trial.
Cited by
-
Coronary imaging characteristics and risk factors in patients with type 2 diabetes mellitus with coronary heart disease complication.World J Diabetes. 2025 Apr 15;16(4):99151. doi: 10.4239/wjd.v16.i4.99151. World J Diabetes. 2025. PMID: 40236865 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical